RKI Reports Nearly Half of Germans Will Develop Cancer in Their Lifetime

According to recent data from the Robert Koch Institute (RKI), almost one in two individuals in Germany is expected to be diagnosed with cancer at some point in their lives. The RKI's latest epidemiological findings reveal that approximately 49 percent of men and 43 percent of women in the country are affected by a cancer diagnosis during their lifetime.

The risk of developing cancer is not limited to older populations. The report indicates that nearly one in six women and one in seven men in Germany receive a cancer diagnosis before reaching the age of 65. In 2023, there were around 517,800 new cancer cases recorded nationwide, comprising approximately 276,400 men and 241,400 women.

The analysis highlights that a significant portion of new diagnoses involves a small number of cancer types. Prostate cancer remains the most common among men, with around 79,600 new cases in 2023. In women, breast cancer is the most prevalent, with approximately 75,900 new diagnoses. Lung cancer and colorectal (including both colon and rectal) cancers also represent a substantial share, accounting for 58,300 and 55,300 new cases respectively.

Mortality data from the same period show that cancer continues to be one of the leading causes of death in Germany. In 2023, there were about 229,000 deaths attributed to cancer, with 123,000 men and 106,000 women succumbing to the disease. These figures were compiled in collaboration with the German Cancer Registry and the Center for Cancer Registry Data at the RKI.

The RKI emphasizes the ongoing importance of cancer awareness, early detection, and prevention measures. Regular screening programs and health education are considered vital tools in reducing the burden of cancer and improving outcomes for those affected. The institute also highlights ongoing research and developments in cancer treatment and prevention as central to national health strategies.

The release of this data coincides with World Cancer Day, an international initiative aimed at raising global awareness of cancer, promoting prevention, and encouraging early intervention. The RKI uses this occasion to share up-to-date findings and underscore the significance of collective efforts in tackling cancer at both the individual and societal levels.

Overall, the data provided by the RKI serve as a reminder of the persistent challenge cancer poses to public health in Germany. With nearly half of the population expected to face a cancer diagnosis during their lifetime, continued focus on prevention, research, and access to effective care remains essential.